Remdesivir Potentially Most Effective For Coronavirus: China Investigator

 
• By Brian Yang

Although AbbVie’s Kaletra has shown promising efficacy in COVID-19 patients, Gilead’s remdesivir has stronger antiviral activity, says one Chinese investigator leading studies in the coronavirus outbreak epicenter Wuhan.

CHINA PRIMARY INVESTIGATOR SAYS REMDESIVIR HAS HIGH POTENTIAL IN COVID-19 • Source: Shutterstock

More from Clinical Trials

More from R&D